Moreover, baseline anti-HBc levels, combining vascular invasion and alpha-fetoprotein (AFP) levels might be a novel biomarker for predicting the survival of hepatocellular carcinoma patients after transarterial chemoembolization11. The gene discussed is AFP; the disease is hepatocellular carcinoma.